TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
VixiMed AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,875
|
2,084
|
1,869 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-88
|
225
|
-350 |
| EBITDA |
-95
|
222
|
-338 |
| Total assets |
1,093
|
1,219
|
1,085 |
| Current assets |
1,076
|
1,219
|
1,045 |
| Current liabilities |
455
|
410
|
435 |
| Equity capital |
638
|
809
|
650 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.4%
|
66.4%
|
59.9% |
| Turnover per employee |
1,875
|
2,084
|
1,869 |
| Profit as a percentage of turnover |
-4.7%
|
10.8%
|
-18.7% |
| Return on assets (ROA) |
-8.1%
|
18.5%
|
-32.3% |
| Current ratio |
236.5%
|
297.3%
|
240.2% |
| Return on equity (ROE) |
-13.8%
|
27.8%
|
-53.8% |
| Change turnover |
-209
|
215
|
-508 |
| Change turnover % |
-10%
|
12%
|
-21% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.